Sorafenib抗藥性所誘發之肝癌惡病質與癌幹細胞特性之細胞療法:利用全身安全性之人類胎盤蛻膜間葉幹細胞標靶TNFα-IL6之免疫調控與攜帶奈米藥物對抗Sorafenib抗藥性肝癌之雙功能策略(先期補助)

Project: A - Government Institutionf - Other (Funded by Government)

StatusFinished
Effective start/end date8/1/177/31/18